Profile
Mr. Jim E.
Daverman is Chairman at CollaGenex Pharmaceuticals, Inc. and Operating Partner & Senior Advisor at Robert W.
Baird & Co., Inc.
Prior to joining Robert w.
Baird in 2003, Mr. Daverman was employed as Co-Chairman at Marshall Erdman & Associates, Inc., Founder at Wind Point Partners, Operating Partner at Baird Venture Partners, Managing Partner at Marquette Venture Partners.
He worked at Madison Dearborn Partners LLC.
He also served on the board at PharMEDium Healthcare Corp.
Mr. Daverman received his BBA degree from the University of Michigan - Stephen M.
Ross School of Business and his MBA in Finance from the University of Pennsylvania - The Wharton School.
Jim E. Daverman active positions
| Companies | Position | Start |
|---|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Chairman | 01/11/1995 |
Former positions of Jim E. Daverman
| Companies | Position | End |
|---|---|---|
Robert W. Baird & Co., Inc. (Private Equity)
Robert W. Baird & Co., Inc. (Private Equity) Investment ManagersFinance Robert W Baird invests in lower middle market companies located in the United States, United Kingdom and Asia with an EBITDA of USD 5 – 15 million and revenues of USD 40 – 260 million. The firm focuses on B2B tech & services, healthcare, industrial solutions & technology and services sectors. It participates in later, growth and buyout stage capital transactions with an investment size of USD 25 – 75 million. The firm acquires majority, minority and controlling interest, and makes co-investments. It also takes a seat on the board of directors. | Private Equity Investor | 31/12/2013 |
Marshall Erdman & Associates, Inc.
Marshall Erdman & Associates, Inc. Engineering & ConstructionIndustrial Services Engages in the planning, design, and construction of healthcare facilities | Chairman | 28/12/2011 |
Marquette Venture Partners
Marquette Venture Partners Investment ManagersFinance Marquette Venture Partners invests in companies located in the United States. The firm focuses on healthcare, information technology and consumer services sectors. It participates in early and growth stage capital requirements. | Corporate Officer/Principal | 01/01/2003 |
PharMEDium Healthcare LLC
PharMEDium Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides hospital pharmacy-outsourced sterile compounding services | Director/Board Member | - |
Wind Point Advisors LLC
Wind Point Advisors LLC Investment ManagersFinance Wind Point Advisors invests in middle market companies located in the United States with an EBITDA of at least USD 10 million and enterprise value of USD 100 - 500 million. The firm focuses on industrial products, consumer products and business services. It participates in buyout and add-on acquisition transactions with an investment size of USD 50 - 300 million. The firm acquires controlling interest and it takes a seat on the board of directors. | Corporate Officer/Principal | - |
Training of Jim E. Daverman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Health Technology |
Marquette Venture Partners
Marquette Venture Partners Investment ManagersFinance Marquette Venture Partners invests in companies located in the United States. The firm focuses on healthcare, information technology and consumer services sectors. It participates in early and growth stage capital requirements. | Finance |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wind Point Advisors LLC
Wind Point Advisors LLC Investment ManagersFinance Wind Point Advisors invests in middle market companies located in the United States with an EBITDA of at least USD 10 million and enterprise value of USD 100 - 500 million. The firm focuses on industrial products, consumer products and business services. It participates in buyout and add-on acquisition transactions with an investment size of USD 50 - 300 million. The firm acquires controlling interest and it takes a seat on the board of directors. | Finance |
Robert W. Baird & Co., Inc. (Private Equity)
Robert W. Baird & Co., Inc. (Private Equity) Investment ManagersFinance Robert W Baird invests in lower middle market companies located in the United States, United Kingdom and Asia with an EBITDA of USD 5 – 15 million and revenues of USD 40 – 260 million. The firm focuses on B2B tech & services, healthcare, industrial solutions & technology and services sectors. It participates in later, growth and buyout stage capital transactions with an investment size of USD 25 – 75 million. The firm acquires majority, minority and controlling interest, and makes co-investments. It also takes a seat on the board of directors. | Finance |
Marshall Erdman & Associates, Inc.
Marshall Erdman & Associates, Inc. Engineering & ConstructionIndustrial Services Engages in the planning, design, and construction of healthcare facilities | Industrial Services |
PharMEDium Healthcare LLC
PharMEDium Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides hospital pharmacy-outsourced sterile compounding services | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madison Dearborn Partners LLC
Madison Dearborn Partners LLC Investment ManagersFinance Madison Dearborn Partners invests in companies located in the United States. The firm focuses on financial & transaction services, technology & government and healthcare sectors. It provides financing for buyout and growth stage capital requirements. It also acquires minority and controlling interest. | Finance |
Robert W. Baird & Co., Inc. /Venture Partners/
Robert W. Baird & Co., Inc. /Venture Partners/ Investment ManagersFinance Baird Capital invests in middle market companies located in the United States with annual revenues of USD 5 - 25 million. The firm focuses on B2B technology & services sector. It participates in early to growth stage transactions with an investment size ranging from USD 15 to 25 million. It acquires majority and minority interest and also takes a seat on the board of directors. | Finance |
- Stock Market
- Insiders
- Jim E. Daverman
















